advertisement
Zangwill LM 24
Showing records 1 to 24 | Display all abstracts from Zangwill LM91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
El-Nimri NW
Scientific reports 2020; 10: 21752
91564 Central Visual Field Defects in Patients with Distinct Glaucomatous Optic Disc Phenotypes
Ekici E
American Journal of Ophthalmology 2021; 223: 229-240
91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
El-Nimri NW
Scientific reports 2020; 10: 21752
91055 Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
Baxter SL; Keenan WT
Scientific reports 2020; 10: 19013
91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Moore SM
Scientific reports 2020; 10: 21752
91564 Central Visual Field Defects in Patients with Distinct Glaucomatous Optic Disc Phenotypes
Moghimi S; Hou H; Hou H
American Journal of Ophthalmology 2021; 223: 229-240
91055 Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
Athanas AJ
Scientific reports 2020; 10: 19013
91564 Central Visual Field Defects in Patients with Distinct Glaucomatous Optic Disc Phenotypes
Hou H
American Journal of Ophthalmology 2021; 223: 229-240
91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Zangwill LM; Proudfoot JA
Scientific reports 2020; 10: 21752
91055 Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
Proudfoot JA
Scientific reports 2020; 10: 19013
91564 Central Visual Field Defects in Patients with Distinct Glaucomatous Optic Disc Phenotypes
Proudfoot J; Proudfoot J
American Journal of Ophthalmology 2021; 223: 229-240
91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Weinreb RN
Scientific reports 2020; 10: 21752
91055 Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
Zangwill LM
Scientific reports 2020; 10: 19013
91564 Central Visual Field Defects in Patients with Distinct Glaucomatous Optic Disc Phenotypes
Zangwill LM; Do JL
American Journal of Ophthalmology 2021; 223: 229-240
91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Skowronska-Krawczyk D
Scientific reports 2020; 10: 21752
91055 Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
Ayyagari R
Scientific reports 2020; 10: 19013
91564 Central Visual Field Defects in Patients with Distinct Glaucomatous Optic Disc Phenotypes
Oh WH
American Journal of Ophthalmology 2021; 223: 229-240
91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
Baxter SL
Scientific reports 2020; 10: 21752
91055 Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
Liebmann JM
Scientific reports 2020; 10: 19013
91564 Central Visual Field Defects in Patients with Distinct Glaucomatous Optic Disc Phenotypes
Kamalipour A
American Journal of Ophthalmology 2021; 223: 229-240
91055 Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
Girkin CA; Patapoutian A
Scientific reports 2020; 10: 19013
91564 Central Visual Field Defects in Patients with Distinct Glaucomatous Optic Disc Phenotypes
Liebmann JM
American Journal of Ophthalmology 2021; 223: 229-240
91055 Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
Weinreb RN
Scientific reports 2020; 10: 19013
91564 Central Visual Field Defects in Patients with Distinct Glaucomatous Optic Disc Phenotypes
De Moraes CG; Girkin CA; El-Nimri N; Weinreb RN
American Journal of Ophthalmology 2021; 223: 229-240
